Blog & Newsroom
Gastroesophageal reflux disease (GERD) is a chronic condition characterized by acid flowing back up the esophagus from the stomach. It affects an estimated 18-28 percent of adults in North America.
Irritable bowel syndrome (IBS), the most prevalent of functional gastrointestinal disorders, is commonly diagnosed by gastroenterologists and primary care physicians. Recurrent abdominal pain and altered bowel habits, along with bloating and distention, are typical features of IBS. It impacts up to 15 percent of adults and interferes with patients’ daily lives. Economically, IBS is associated with reduced productivity and poses a burden to the healthcare system. Amid quantifiable costs measured by outpatient visits, diagnostic tests, and medications, the individual patient’s quality of life suffers with no single go-to therapy.
Colonoscopy is the preferred colorectal cancer prevention test because it has the highest sensitivity for colorectal cancer and precancerous polyps can be detected and removed in one procedure.